Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer Group.
Ashish M KamatAndrea B ApoloMarek BabjukTrinity J BivalacquaPeter C BlackRoger BuckleyMatthew T CampbellEva CompératJason Alexander EfstathiouPetros D GrivasShilpa GuptaNeil J KurtzDonald LammSeth P LernerRoger LiDavid J McConkeyJoan Palou RedortaThomas PowlesSarah P PsutkaNeal D ShoreGary D SteinbergRichard SylvesterJ Alfred WitjesMatthew D GalskyPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
These recommendations developed by the SITC-IBCG Bladder Cancer Clinical Trial Design consensus panel will encourage uniformity among studies and facilitate drug development in this disease.